Effects of Atorvastatin (10 mg) on hemostatic and inflammatory parameters in hyperlipidemic patients with angiographically proven coronary artery disease


TEKIN A., TEKIN G., GUZELSOY D. , Kaya A. , GUREL C. , YIGIT Z. , et al.

AMERICAN JOURNAL OF CARDIOLOGY, cilt.94, ss.206-209, 2004 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 94 Konu: 2
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1016/j.amjcard.2004.03.065
  • Dergi Adı: AMERICAN JOURNAL OF CARDIOLOGY
  • Sayfa Sayısı: ss.206-209

Özet

Hyperlipidemic patients with coronary heart disease were treated with atorvastatin, and its effects on hemostatic and inflammatory parameters were assessed. After 3 months of therapy, the plasma levels of plasminogen activator inhibitor, prothrombin fragment 1+2, highly sensitive C-reactive protein, von Willebrand factor, and fibrinogen were significantly reduced; no significant reductions were observed in lipoprotein(a) and tissue plasminogen activator antigen levels. (C) 2004 by Excerpta Medica, Inc.